OpenAI Launches GPT-Rosalind, A Frontier AI Model Built For Life Sciences That Outperforms Human Experts On Key Biology Benchmarks
OpenAI launches GPT-Rosalind, a frontier AI model purpose-built for life sciences that outperforms human experts above the 95th percentile on RNA sequence-to-function tasks, beats competitors on key benchmarks, and is now available in research preview for U.S. Enterprise customers through partnerships with Amgen, Moderna, and the Allen Institute.